Details for New Drug Application (NDA): 215761
✉ Email this page to a colleague
The generic ingredient in SOLIFENACIN SUCCINATE is solifenacin succinate. There are thirty drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the solifenacin succinate profile page.
Summary for 215761
Tradename: | SOLIFENACIN SUCCINATE |
Applicant: | Annora Pharma |
Ingredient: | solifenacin succinate |
Patents: | 0 |
Pharmacology for NDA: 215761
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for 215761
Suppliers and Packaging for NDA: 215761
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 215761 | ANDA | Camber Pharmaceuticals, Inc. | 31722-027 | 31722-027-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-027-30) |
SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 215761 | ANDA | Camber Pharmaceuticals, Inc. | 31722-027 | 31722-027-31 | 10 BLISTER PACK in 1 CARTON (31722-027-31) / 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-027-32) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Jun 15, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Jun 15, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription